EP 3580344 A4 20201118 - VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME
Title (en)
VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME
Title (de)
VCN-FÖRDERER-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON
Title (fr)
COMPOSITIONS D'AUGMENTATION DU NCV ET PROCÉDÉS D'UTILISATION DE CES DERNIÈRES
Publication
Application
Priority
- US 201762457504 P 20170210
- US 2018017557 W 20180209
Abstract (en)
[origin: WO2018148502A1] The invention provides improved adoptive immunotherapy compositions and methods of making the same.
IPC 8 full level
C12N 15/86 (2006.01); A61K 9/00 (2006.01); A61K 39/00 (2006.01); A61K 47/10 (2017.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 9/0019 (2013.01 - EP US); A61K 35/17 (2013.01 - US); A61K 39/461 (2023.05 - EP); A61K 39/4631 (2023.05 - EP); A61K 39/4632 (2023.05 - EP); A61K 39/464488 (2023.05 - EP); A61K 47/10 (2013.01 - EP US); A61P 35/00 (2017.12 - EP); C12N 15/86 (2013.01 - EP US); A61K 31/4439 (2013.01 - US); A61K 31/4709 (2013.01 - US); A61K 31/52 (2013.01 - US); A61K 31/5377 (2013.01 - US); C07K 14/7051 (2013.01 - EP); C07K 2319/03 (2013.01 - EP); C12N 2740/16043 (2013.01 - EP US)
Citation (search report)
- [YD] WO 2013127964 A1 20130906 - HELMHOLTZ ZENTRUM MUENCHEN [DE], et al
- [Y] WO 2016201394 A1 20161215 - MILTENYI BIOTEC TECH INC [US]
- See references of WO 2018148502A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2018148502 A1 20180816; EP 3580344 A1 20191218; EP 3580344 A4 20201118; US 2019365814 A1 20191205
DOCDB simple family (application)
US 2018017557 W 20180209; EP 18751122 A 20180209; US 201816485048 A 20180209